Janus Henderson Group PLC Abiomed Inc Transaction History

Janus Henderson Group PLC

$187 Billion
Q3 2024

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$242.49 - $301.46 $214,603 - $266,792	-885 Reduced 14.77%	5,106 $1.26 Million
Q2 2022 Aug 15, 2022	SELL	$224.73 - $338.64 $4.82 Million - $7.26 Million	-21,434 Reduced 78.15%	5,991 $1.48 Million
Q1 2022 May 16, 2022	SELL	$277.25 - $366.29 $7.12 Million - $9.4 Million	-25,670 Reduced 48.35%	27,425 $9.08 Million
Q4 2021 Feb 14, 2022	SELL	$300.63 - $371.35 $8.49 Million - $10.5 Million	-28,232 Reduced 34.71%	53,095 $19.1 Million
Q3 2021 Nov 16, 2021	BUY	$310.19 - $376.2 $579,434 - $702,741	1,868 Added 2.35%	81,327 $26.5 Million
Q2 2021 Aug 16, 2021	SELL	$262.71 - $351.17 $10.8 Million - $14.4 Million	-41,074 Reduced 34.08%	79,459 $24.8 Million
Q1 2021 May 17, 2021	BUY	$285.92 - $355.13 $14.6 Million - $18.1 Million	51,061 Added 73.5%	120,533 $38.4 Million
Q4 2020 Feb 16, 2021	SELL	$251.88 - $324.2 $17.4 Million - $22.4 Million	-69,088 Reduced 49.86%	69,472 $22.5 Million
Q3 2020 Nov 16, 2020	BUY	$255.22 - $317.0 $4.41 Million - $5.47 Million	17,265 Added 14.23%	138,560 $38.4 Million
Q2 2020 Aug 14, 2020	BUY	$141.4 - $257.09 $8.9 Million - $16.2 Million	62,943 Added 107.87%	121,295 $29.3 Million
Q1 2020 May 14, 2020	SELL	$130.51 - $196.01 $25.3 Million - $38 Million	-193,828 Reduced 76.86%	58,352 $8.47 Million
Q4 2019 Feb 18, 2020	SELL	$159.31 - $223.54 $6.6 Million - $9.26 Million	-41,411 Reduced 14.1%	252,180 $43 Million
Q3 2019 Nov 14, 2019	SELL	$175.89 - $279.23 $46.3 Million - $73.5 Million	-263,098 Reduced 47.26%	293,591 $52.2 Million
Q2 2019 Jul 31, 2019	SELL	$250.96 - $284.94 $24.1 Million - $27.3 Million	-95,865 Reduced 14.69%	556,689 $145 Million
Q1 2019 Apr 30, 2019	SELL	$276.39 - $362.25 $19.2 Million - $25.1 Million	-69,412 Reduced 9.61%	652,554 $186 Million
Q4 2018 Feb 06, 2019	BUY	$281.08 - $444.25 $57.4 Million - $90.8 Million	204,354 Added 39.48%	721,966 $235 Million
Q3 2018 Nov 09, 2018	BUY	$354.53 - $449.75 $87 Million - $110 Million	245,286 Added 90.07%	517,612 $233 Million
Q2 2018 Aug 10, 2018	SELL	$278.07 - $446.21 $52.4 Million - $84.1 Million	-188,503 Reduced 40.91%	272,326 $111 Million
Q1 2018 May 14, 2018	SELL	$192.49 - $295.85 $28.2 Million - $43.3 Million	-146,314 Reduced 24.1%	460,829 $134 Million
Q4 2017 Feb 09, 2018	SELL	$168.78 - $199.74 $79.3 Million - $93.8 Million	-469,686 Reduced 43.62%	607,143 $114 Million
Q3 2017 Nov 14, 2017	BUY	$145.39 - $168.6 $79.1 Million - $91.7 Million	543,793 Added 102.02%	1,076,829 $0
Q2 2017 Aug 17, 2017	BUY	N/A	533,036	533,036 $76.4 Million

Others Institutions Holding ABMD

# of Institutions

Shares Held

137K

Call Options Held

Put Options Held

View Full List

About ABIOMED INC

Ticker ABMD
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 45,460,900
Description
Abiomed, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It also provides a continuum of care to heart failure patients. The company offers Impella 2.5, a percutaneous micro heart pump with integrated motor and sensors; and Impella CP, a device for use by inte...

More about ABMD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Janus Henderson Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Janus Henderson Group PLC with notifications on news.

Account